Marché américain de la surveillance thérapeutique à distance (MSK) – Tendances et prévisions du secteur jusqu’en 2030

Analyse et taille du marché de la surveillance thérapeutique à distance (MSK) aux États-Unis

La présence de ces entreprises génère des prix compétitifs pour la surveillance thérapeutique à distance dans toute la région. En raison de la présence de ces acteurs aux niveaux régional et international, les fournisseurs et fabricants proposent des produits aux spécifications et caractéristiques différentes pour tous les budgets. L'intégration croissante de l'intelligence artificielle et de l'apprentissage automatique stimule la croissance du marché. La demande croissante de surveillance thérapeutique à distance devrait stimuler la croissance du marché.

Data Bridge Market Research estime que le marché américain de la télésurveillance thérapeutique (MSK) devrait atteindre 2 350,10 millions USD d'ici 2030, à un TCAC de 18,3 % au cours de la période de prévision. Ce rapport de marché couvre également en profondeur l'analyse des prix et les avancées technologiques.

Définition du marché

Le marché de la télésurveillance thérapeutique (RTM) aux États-Unis fait référence au segment du secteur de la santé qui se concentre sur la surveillance et la gestion à distance des troubles musculo-squelettiques (MSK) à l'aide de technologies numériques. Il englobe les outils de télésanté et de télésurveillance pour fournir une évaluation, une surveillance et un soutien continus aux personnes atteintes de troubles musculo-squelettiques, permettant aux prestataires de soins de santé de suivre et de gérer à distance la santé musculo-squelettique de leurs patients.

In the RTM market, healthcare providers leverage wearable devices, mobile applications, telehealth platforms, and remote monitoring software to monitor MSK patients remotely. These tools enable data collection related to patient symptoms, mobility, exercise routines, adherence to treatment plans, and other relevant parameters.

U.S. Remote Therapeutic Monitoring (MSK) Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

• Rising Technological Advancements

Rapid technological advancements, including wearable devices, mobile apps, and telehealth platforms, have facilitated remote therapeutic monitoring. These technologies provide real-time data collection, transmission, and analysis, allowing healthcare providers to remotely monitor patients' vital signs, medication adherence, and overall health. Technological advancements have led to the development of wearable devices and sensors that can monitor various MSK (musculoskeletal) parameters such as movement, posture, range of motion, muscle activity, and joint pressure. These devices can collect real-time data and provide objective measurements, enabling healthcare providers to monitor patients' MSK conditions and track their progress remotely. Accurate and reliable wearable devices enhance remote therapeutic monitoring for MSK conditions.

For instance,

• In May 2021, as per ScienceDirect, in the past few years, technology has revolutionized the field of motion capture by introducing wearable and optical sensors to enable an automatic acquisition of reliably accurate movement data for biomechanics analysis along with scientific literature on technology-assisted approaches using RGB-D sensors for musculoskeletal health monitoring have been evolved

Integration of Artificial Intelligence (AI) and Machine Learning (ML)

AI and ML technologies are being integrated into remote therapeutic monitoring systems for MSK conditions. These technologies can analyze large datasets, identify trends, and provide predictive analytics. AI-powered algorithms can assist in identifying potential exacerbations, predicting flare-ups, and personalizing treatment plans based on individual patient data. Integrating AI and ML enhances the accuracy and efficiency of remote therapeutic monitoring for MSK conditions.

AI and ML algorithms can process large amounts of data collected from remote monitoring devices, wearables, and other sources. These algorithms can analyze data patterns, trends, and correlations to identify potential indicators of MSK conditions, disease progression, and treatment response. By extracting valuable insights from the data, AI and ML enable more accurate and timely decision-making for healthcare providers, leading to improved patient care and outcomes.

Hence, as per the above discussion, the integration of artificial intelligence (AI) and Machine Learning (ML) is driving the market's growth in the forecast period.

OPPORTUNITY

• Growing Expansion of Telehealth in the U.S.

The expansion of telehealth services and the increased adoption of remote consultations contribute to the growth of musculoskeletal remote therapeutic monitoring. Telehealth platforms allow healthcare providers to remotely assess patients, provide guidance, and monitor treatment progress, improving accessibility and convenience for patients with musculoskeletal conditions.

Telehealth allows patients to access healthcare services remotely, eliminating barriers such as geographical distance and limited healthcare infrastructure. As telehealth expands, more patients can benefit from remote therapeutic monitoring, regardless of location. This increased access opens up opportunities for remote monitoring companies to reach a wider patient population and expand their services. Telehealth platforms provide a means for healthcare providers to monitor patients in real-time remotely. Through video consultations, secure messaging, and remote monitoring devices, healthcare professionals can monitor vital signs, track progress, and assess patient conditions without needing in-person visits. Remote therapeutic monitoring can seamlessly integrate into telehealth platforms, allowing continuous monitoring and personalized care management.

For instance,

•  In November 2020, as per NCBI, government insurance reimbursement policies, particularly, have been shown to influence telemedicine adoption in the U.S.

Results from the November 2022 study by Cision U.S., Inc. found that over 90% of Americans used telehealth services in the last year and that 90% enjoyed their experience. Some of these services included doctor's appointments, teledentistry, and vision appointments

Hence, it can be concluded that the expansion of the telehealth platform is providing an opportunity for market growth in the forecast period.

RESTRAINT / CHALLENGE

• Data Security and Privacy Concerns

The transmission and storage of patient health data in remote monitoring systems raise concerns about data security and privacy. Ensuring the protection of patient information and compliance with regulations, such as HIPAA, is crucial to building trust and encouraging the adoption of remote monitoring technologies.

Data security and privacy concerns can lead to patient reluctance to adopt remote therapeutic monitoring solutions. Patients may hesitate to share sensitive health information and biometric data if they are unsure how their data will be protected and who will have access to it. Lack of trust in the security measures implemented by remote monitoring platforms and healthcare providers can hinder patient engagement and limit the market growth.

For instance,

• In January 2023, as per SmartClinix, Remote Patient Monitoring (RPM) relies on transmitting sensitive medical data over the internet. Thus, security is a significant concern. It's vulnerable to cyber-attacks, data breaches, and various threats. These threats can compromise patients' integrity, availability, and confidentiality. This can lead to grave consequences for both patients and healthcare providers

Hence, as per the above discussion, data security and privacy concerns may restrain the market growth in the forecast period.

• In April 2022, INTELLIH INC. received a Service Organization Control 2 (SOC 2) Certification after a thorough independent third-party audit of the solution architecture, data security, security practices, and operational processes
• In August 2021, Zimmer Biomet and Canary Medical announced the FDA De Novo classification grant and authorization to market the world's first smart knee implant Persona IQ. This has helped the company to strengthen its product portfolio

U.S. Remote Therapeutic Monitoring (MSK) Market Scope

U.S. remote therapeutic monitoring (MSK) market is segmented into nine notable segments based on product, deployment mode, and mode of access, codes, type, application, purchase mode, end users, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Product

• Solutions Software
• Services
• Hardware

On the basis of product, U.S. remote therapeutic monitoring (MSK) market is segmented into solutions software, services, and hardware.

Deployment Mode

• Cloud based
• On premises

On the basis of deployment mode, the U.S. remote therapeutic monitoring (MSK) market is segmented into cloud based and on premises.

Mode of Access

• Mobile based
• Web based

On the basis of mode of access, the U.S. remote therapeutic monitoring (MSK) market is segmented into mobile based and web based.

Codes

• 98975
• 98976
• 98977
• 98980
• 98981

On the basis of codes, the U.S. remote therapeutic monitoring (MSK) market is segmented into 98975, 98976, 98977, 98980, and 98981.

Types

• Continuous monitoring
• Proactive monitoring
• Intermittent Monitoring

On the basis of types, the U.S. remote therapeutic monitoring (MSK) market is segmented into continuous monitoring, proactive monitoring, and intermittent monitoring.

Application

• Non physiological data
• Therapeutic data

On the basis of application, the U.S. remote therapeutic monitoring (MSK) market is segmented into non physiological data, and therapeutic data.

Purchase Mode

• Group purchase
• Individual

On the basis of purchase mode, the U.S. remote therapeutic monitoring (MSK) market is segmented into group purchase and individual.

End Users

• Providers
• Payers
• Patient

On the basis of end users, the U.S. remote therapeutic monitoring (MSK) market is segmented into providers, payers, and patient.

Distribution Channel

• Direct Sales
• Indirect Sales

Sur la base du canal de distribution, le marché américain de la surveillance thérapeutique à distance (MSK) est segmenté en ventes directes et ventes indirectes.

Analyse du paysage concurrentiel et des parts de marché de la surveillance thérapeutique à distance (MSK) aux États-Unis

Le paysage concurrentiel du marché américain de la surveillance thérapeutique à distance (MSK) fournit des détails sur les concurrents. Les détails comprennent un aperçu de l'entreprise, les données financières, les revenus générés, le potentiel du marché, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.

Certains des principaux acteurs du marché opérant sur le marché américain de la surveillance thérapeutique à distance (MSK) sont Zimmer Biomet, Omada Health Inc., HealthViewX, Propeller Health, Limber Health Inc., Murata Vios, Owlytics Healthcare, Medistics LLC., INTELLIH INC., HealthArc, CIPHER SKIN INC., Medsien, Inc., Censon Health et Exer Labs, Inc.

SKU-70172